Clinical Trials Directory

Trials / Completed

CompletedNCT06452082

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

Retrospective Observational Study on the Risk Developing Long-COVID Syndrome After Acute COVID-19 Disease and in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl in Outpatients of Endocr Dept

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this observational retrospective study is to evaluate the effect of supplementation with cholecalciferol D3 in reducing the risk of: * occurence of Long COVID syndrome after acute COVID-19 illness * occurence of SARS-CoV-2 infection after anti-COVID-19 vaccination

Detailed description

Anamnestic, laboratory and therapeutic data will be collected during outpatient visits.

Conditions

Timeline

Start date
2024-03-20
Primary completion
2025-07-24
Completion
2025-09-10
First posted
2024-06-11
Last updated
2026-04-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06452082. Inclusion in this directory is not an endorsement.

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl (NCT06452082) · Clinical Trials Directory